BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 29190656)

  • 1. MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
    Bennani-Baiti B; Dietzel M; Baltzer PA
    PLoS One; 2017; 12(11):e0188679. PubMed ID: 29190656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is breast MRI a helpful additional diagnostic test in suspicious mammographic microcalcifications?
    Baltzer PAT; Bennani-Baiti B; Stöttinger A; Bumberger A; Kapetas P; Clauser P
    Magn Reson Imaging; 2018 Feb; 46():70-74. PubMed ID: 29122667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR Imaging for Diagnosis of Malignancy in Mammographic Microcalcifications: A Systematic Review and Meta-Analysis.
    Bennani-Baiti B; Baltzer PA
    Radiology; 2017 Jun; 283(3):692-701. PubMed ID: 27788035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the role of dynamic contrast-enhanced MR imaging for patients with BI-RADS 3-4 microcalcifications.
    Jiang Y; Lou J; Wang S; Zhao Y; Wang C; Wang D
    PLoS One; 2014; 9(6):e99669. PubMed ID: 24927476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of subcategorizing BI-RADS 4 breast lesions associated with microcalcification: a radiology-pathology correlation study.
    Sanders MA; Roland L; Sahoo S
    Breast J; 2010; 16(1):28-31. PubMed ID: 19929890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scoring System to Stratify Malignancy Risks for Mammographic Microcalcifications Based on Breast Imaging Reporting and Data System 5th Edition Descriptors.
    Youk JH; Gweon HM; Son EJ; Eun NL; Choi EJ; Kim JA
    Korean J Radiol; 2019 Dec; 20(12):1646-1652. PubMed ID: 31854152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US and MRI in the evaluation of mammographic BI-RADS 4 and 5 microcalcifications.
    Hrkac Pustahija A; Ivanac G; Brkljacic B
    Diagn Interv Radiol; 2018 Jul; 24(4):187-194. PubMed ID: 30091708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories.
    Bent CK; Bassett LW; D'Orsi CJ; Sayre JW
    AJR Am J Roentgenol; 2010 May; 194(5):1378-83. PubMed ID: 20410428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of breast MRI for BI-RADS category 4B mammographic microcalcification: based on the 5
    Eun NL; Son EJ; Gweon HM; Youk JH; Kim JA
    Clin Radiol; 2018 Aug; 73(8):750-755. PubMed ID: 29853301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
    Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
    Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the diagnostic value of contrast-enhanced breast MR imaging and mammography on patients with BI-RADS 3-5 microcalcifications.
    Li E; Li J; Song Y; Xue M; Zhou C
    PLoS One; 2014; 9(11):e111217. PubMed ID: 25365327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast MRI as a Problem-solving Study in the Evaluation of BI-RADS Categories 3 and 4 Microcalcifications: Is it Worth Performing?
    Shimauchi A; Machida Y; Maeda I; Fukuma E; Hoshi K; Tozaki M
    Acad Radiol; 2018 Mar; 25(3):288-296. PubMed ID: 29191685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast MRI used as a problem-solving tool reliably excludes malignancy.
    Spick C; Szolar DHM; Preidler KW; Tillich M; Reittner P; Baltzer PA
    Eur J Radiol; 2015 Jan; 84(1):61-64. PubMed ID: 25454098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial.
    Bazzocchi M; Zuiani C; Panizza P; Del Frate C; Soldano F; Isola M; Sardanelli F; Giuseppetti GM; Simonetti G; Lattanzio V; Del Maschio A
    AJR Am J Roentgenol; 2006 Jun; 186(6):1723-32. PubMed ID: 16714666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scoring system based on BI-RADS lexicon to predict probability of malignancy in suspicious microcalcifications.
    Youk JH; Son EJ; Kim JA; Moon HJ; Kim MJ; Choi CH; Kim EK
    Ann Surg Oncol; 2012 May; 19(5):1491-8. PubMed ID: 22173328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling the potential of breast MRI: a game changer for BI-RADS 4A microcalcifications.
    Li S; Lin Y; Liu G; Shao Z; Yang Y
    Breast Cancer Res Treat; 2024 Apr; ():. PubMed ID: 38664289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of magnetic resonance imaging in probably benign (BI-RADS category 3) microcalcifications of the breast.
    Linda A; Zuiani C; Londero V; Di Gaetano E; Dal Col A; Girometti R; Bazzocchi M
    Radiol Med; 2014 Jun; 119(6):393-9. PubMed ID: 24297595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum-assisted breast biopsy in a nonacademic community practice.
    Mendez A; Cabanillas F; Echenique M; Malekshamran K; Perez I; Ramos E
    Cancer; 2004 Feb; 100(4):710-4. PubMed ID: 14770425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.